INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 150 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.69 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,490,000 | +35.7% | 87,213 | +8.5% | 0.00% | 0.0% |
| Q4 2018 | $1,098,000 | -76.2% | 80,417 | -50.0% | 0.00% | -33.3% |
| Q3 2018 | $4,604,000 | +184.5% | 160,834 | +172.0% | 0.00% | +50.0% |
| Q2 2018 | $1,618,000 | +98.5% | 59,131 | +53.0% | 0.00% | +100.0% |
| Q1 2018 | $815,000 | +32.7% | 38,650 | +21.0% | 0.00% | 0.0% |
| Q4 2017 | $614,000 | -5.2% | 31,950 | +22.4% | 0.00% | 0.0% |
| Q3 2017 | $648,000 | +55.4% | 26,094 | +0.1% | 0.00% | 0.0% |
| Q2 2017 | $417,000 | +167.3% | 26,070 | +135.3% | 0.00% | – |
| Q1 2017 | $156,000 | +8.3% | 11,079 | +0.8% | 0.00% | – |
| Q4 2016 | $144,000 | -23.0% | 10,990 | 0.0% | 0.00% | – |
| Q3 2016 | $187,000 | -20.4% | 10,990 | 0.0% | 0.00% | – |
| Q2 2016 | $235,000 | – | 10,990 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,216,340 | $62,958,000 | 7.04% |
| Discovery Value Fund | 584,483 | $30,253,000 | 6.33% |
| MPM BioImpact LLC | 299,409 | $15,497,000 | 4.30% |
| ARK Investment Management | 9,514,580 | $439,003,000 | 2.60% |
| Elmwood Wealth Management, Inc. | 67,899 | $3,514,000 | 2.00% |
| Nikko Asset Management Americas, Inc. | 2,781,136 | $141,143,000 | 1.74% |
| Avidity Partners Management LP | 1,125,194 | $58,240,000 | 1.34% |
| Merlin Capital, Inc | 12,174 | $630,000 | 1.26% |
| Atlas Venture Associates IX, LLC | 10,000 | $518,000 | 1.18% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $5,768,000 | 1.16% |